| Identification | Back Directory | [Name]
Bafetinib | [CAS]
887650-05-7 | [Synonyms]
Lyn-IN-1
bafetinib
Bafetinib, >=98%
Bafetinib analog
Bafetinib USP/EP/BP
Lyn-IN-1 (Synonyms: Bafetinib analog)
(S)-N-(3-(5,5'-Bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)-pyrrolidin-1-yl)me
(S)-N-(3-([5,5'-bipyriMidin]-2-ylaMino)-4-Methylphenyl)-4-((3-(diMethylaMino)pyrrolidin-1-yl)Methyl)-3-(trifluoroMethyl)benzaMide
N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide
Benzamide, N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-
4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(5-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | [EINECS(EC#)]
1312995-182-4 | [Molecular Formula]
C30H31F3N8O | [MDL Number]
MFCD11973647 | [MOL File]
887650-05-7.mol | [Molecular Weight]
576.62 |
| Hazard Information | Back Directory | [Uses]
A substituted benzamide derivative structurally related to STI-571 (Imatinib Mesylate). It was identified as highly potent Bcr-Abl kinase inhibitor. |
|
|